We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ORX.ST

Price
14.00
Stock movement down
-0.16 (-1.13%)
Company name
Orexo AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
483.07M
Ent value
1.09B
Price/Sales
0.81
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-14.63%
3 year return
-10.91%
5 year return
-25.95%
10 year return
-19.37%
Last updated: 2025-04-12

DIVIDENDS

ORX.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA13.46
EV to EBITDA30.43

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.81
Price to Book-
EV to Sales1.83

FINANCIALS

Per share

Per share data
Current share count34.51M
EPS (TTM)-3.04
FCF per share (TTM)-1.31

Income statement

Income statement data
Revenue (TTM)595.80M
Gross profit (TTM)463.60M
Operating income (TTM)-52.70M
Net income (TTM)-105.30M
EPS (TTM)-3.04
EPS (1y forward)-2.30

Margins

Margins data
Gross margin (TTM)77.81%
Operating margin (TTM)-8.85%
Profit margin (TTM)-17.67%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash114.90M
Net receivables245.20M
Total current assets414.40M
Goodwill0.00
Intangible assets142.60M
Property, plant and equipment0.00
Total assets697.00M
Accounts payable114.50M
Short/Current long term debt581.00M
Total current liabilities244.20M
Total liabilities724.20M
Shareholder's equity-27.20M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-41.40M
Capital expenditures (TTM)3.90M
Free cash flow (TTM)-45.30M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-15.11%
Return on Invested Capital736.36%
Cash Return on Invested Capital316.78%

STOCK INFORMATION

Stock chart

Stock price data
Open14.30
Daily high14.30
Daily low13.54
Daily Volume1K
All-time high182.00
1y analyst estimate18.50
Beta0.60
EPS (TTM)-3.04
Dividend per share-
Ex-div date-
Next earnings date6 May 2025

Downside potential

Downside potential data
ORX.STS&P500
Current price drop from All-time high-92.31%-12.89%
Highest price drop-95.06%-56.47%
Date of highest drop12 Jun 20239 Mar 2009
Avg drop from high-66.14%-11.07%
Avg time to new high188 days12 days
Max time to new high2855 days1805 days
COMPANY DETAILS
ORX.ST (Orexo AB) company logo
Marketcap
483.07M
Marketcap category
Small-cap
Description
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Employees
113
Website
https://www.orexo.com
Investor relations
-
SEC filings
ORX.ST SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved